Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 50619

1.

Circadian rhythms and rheumatoid arthritis.

Maurizio C.

Joint Bone Spine. 2018 Sep 15. pii: S1297-319X(18)30178-7. doi: 10.1016/j.jbspin.2018.09.003. [Epub ahead of print]

PMID:
30227223
2.

Glycolysis Inhibitors Monoiodoacetate and 2-Deoxyglucose as Antitumor Agents: Experimental Study on Lewis Lung Carcinoma Model.

Korshunov DA, Klimov IA, Ivanov VV, Kondakova IV.

Bull Exp Biol Med. 2018 Sep 17. doi: 10.1007/s10517-018-4244-1. [Epub ahead of print]

PMID:
30225703
3.

Improved microfluidic platform for simultaneous multiple drug screening towards personalized treatment.

Mitxelena-Iribarren O, Zabalo J, Arana S, Mujika M.

Biosens Bioelectron. 2018 Sep 2. pii: S0956-5663(18)30689-4. doi: 10.1016/j.bios.2018.09.001. [Epub ahead of print]

PMID:
30224287
4.

The role of genetic polymorphisms in the thymidylate synthase (TYMS) gene in methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia.

Oosterom N, Berrevoets M, den Hoed MAH, Zolk O, Hoerning S, Pluijm SMF, Pieters R, de Jonge R, Tissing WJE, van den Heuvel-Eibrink MM, Heil SG.

Pharmacogenet Genomics. 2018 Sep 14. doi: 10.1097/FPC.0000000000000352. [Epub ahead of print]

PMID:
30222710
5.

Low Persistence Rates in Rheumatoid Arthritis Patients Treated with Triple Therapy are Attributed to Adverse Drug Events Associated with Sulfasalazine.

Erhardt DP, Cannon GW, Teng CC, Mikuls TR, Curtis JR, Sauer BC.

Arthritis Care Res (Hoboken). 2018 Sep 17. doi: 10.1002/acr.23759. [Epub ahead of print]

PMID:
30221485
6.

Safety of anti-rheumatic drugs in men trying to conceive: A systematic review and analysis of published evidence.

Mouyis M, Flint JD, Giles IP.

Semin Arthritis Rheum. 2018 Aug 17. pii: S0049-0172(18)30194-X. doi: 10.1016/j.semarthrit.2018.07.011. [Epub ahead of print]

PMID:
30220537
7.

Clinical effectiveness and long-term retention of abatacept in elderly rheumatoid arthritis patients: Results from a multicenter registry system.

Takahashi N, Kojima T, Kida D, Kaneko A, Hirano Y, Fujibayashi T, Yabe Y, Takagi H, Oguchi T, Hanabayashi M, Kato T, Funahashi K, Hayashi M, Tsuboi S, Kanayama Y, Sobue Y, Asai N, Matsumoto T, Watanabe T, Asai S, Ishiguro N.

Mod Rheumatol. 2018 Sep 15:1-23. doi: 10.1080/14397595.2018.1525019. [Epub ahead of print]

PMID:
30220237
8.

Safety and Impact of Low-Dose Methotrexate on Endothelial Function and Inflammation in Individuals with Treated Human Immunodeficiency Virus: AIDS Clinical Trials Group Study A5314.

Hsue PY, Ribaudo HJ, Deeks SG, Bell T, Ridker PM, Fichtenbaum C, Daar ES, Havlir D, Yeh E, Tawakol A, Lederman M, Currier JS, Stein JH.

Clin Infect Dis. 2018 Sep 14. doi: 10.1093/cid/ciy781. [Epub ahead of print]

PMID:
30219823
9.

Complement C5-blocking Agent in Refractory Dermatomyositis.

Faguer S, Belliere J, Ribes D.

J Rheumatol. 2018 Sep 15. pii: jrheum.180060. doi: 10.3899/jrheum.180060. [Epub ahead of print]

PMID:
30219762
10.

Safety and effectiveness of abatacept in Japanese non-elderly and elderly patients with rheumatoid arthritis in an all-cases post-marketing surveillance.

Harigai M, Ishiguro N, Inokuma S, Mimori T, Ryu J, Takei S, Takeuchi T, Tanaka Y, Takasaki Y, Yamanaka H, Yoshizawa Y, Chinen I, Nakao T, Koike T.

Mod Rheumatol. 2018 Sep 14:1-23. doi: 10.1080/14397595.2018.1524998. [Epub ahead of print]

PMID:
30217117
11.

Targeted therapies for pediatric psoriasis.

Schwartz G, Paller AS.

Semin Cutan Med Surg. 2018 Sep;37(3):167-172. doi: 10.12788/j.sder.2018.048.

PMID:
30215634
12.

An immune tolerance approach using transient low-dose methotrexate in the ERT-naïve setting of patients treated with a therapeutic protein: experience in infantile-onset Pompe disease.

Kazi ZB, Desai AK, Troxler RB, Kronn D, Packman S, Sabbadini M, Rizzo WB, Scherer K, Abdul-Rahman O, Tanpaiboon P, Nampoothiri S, Gupta N, Feigenbaum A, Niyazov DM, Sherry L, Segel R, McVie-Wylie A, Sung C, Joseph AM, Richards S, Kishnani PS.

Genet Med. 2018 Sep 14. doi: 10.1038/s41436-018-0270-7. [Epub ahead of print]

PMID:
30214072
13.

Improving outcomes in primary CNS lymphoma.

Graham MS, DeAngelis LM.

Best Pract Res Clin Haematol. 2018 Sep;31(3):262-269. doi: 10.1016/j.beha.2018.07.006. Epub 2018 Jul 21. Review.

PMID:
30213395
14.

Facial solitary morphea profunda presenting with painful trigeminal neuropathy: A case report.

Moreno-Ajona D, Moreno-Artero E, García de Eulate MR, Irimia P, España A.

Cephalalgia. 2018 Sep 13:333102418801580. doi: 10.1177/0333102418801580. [Epub ahead of print]

PMID:
30213201
15.

Successful management of a spontaneous viable monochorionic diamniotic twin pregnancy on cesarean scar with systemic methotrexate: A case report.

Baradwan S, Khan F, Al-Jaroudi D.

Medicine (Baltimore). 2018 Sep;97(37):e12343. doi: 10.1097/MD.0000000000012343.

16.

Effects of Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Response to Periodontal Treatment in Patients with Rheumatoid Arthritis.

Jung GU, Han JY, Hwang KG, Park CJ, Stathopoulou PG, Fiorellini JP.

Biomed Res Int. 2018 Aug 19;2018:1465402. doi: 10.1155/2018/1465402. eCollection 2018.

17.

An analysis of the biological disease-modifying antirheumatic drug-free condition of adalimumab-treated rheumatoid arthritis patients.

Ito S, Kobayashi D, Hasegawa E, Takai C, Nemoto T, Lee H, Abe A, Otani H, Ishikawa H, Murasawa A, Narita I, Nakazono K.

Intern Med. 2018 Sep 12. doi: 10.2169/internalmedicine.1332-18. [Epub ahead of print]

18.

Gemcitabine, cisplatin, and dexamethasone (GDP) in combination with methotrexate and pegaspargase is active in newly diagnosed peripheral T cell lymphoma patients: a phase 2, single-center, open-label study in China.

Zhang Y, Zhang W, Li J, Duan M, Han B, Zhu T, Zhuang J, Cai H, Cao X, Chen M, Zhou D.

Ann Hematol. 2018 Sep 12. doi: 10.1007/s00277-018-3488-1. [Epub ahead of print]

PMID:
30209556
19.

Clinical Usefulness of Magnetic Resonance Imaging in Four Children With Scleroderma.

Agata K, Kawashima H, Kumada A, Kashiwagi Y, Hara H.

Arch Rheumatol. 2017 Nov 2;33(2):230-235. doi: 10.5606/ArchRheumatol.2018.6498. eCollection 2018 Jun.

20.

Supplemental Content

Loading ...
Support Center